Arrhythmia Monitoring Devices Market – Highlights
The Global Arrhythmia Monitoring Devices Market is expected to register a growth of
significant CAGR 7.0% during the forecast period (2018–2023). Arrhythmia relates to
unequal rate or irregular rhythm of heartbeat, and while most of these conditions are fairly
harmless, certain cases can be completely serious and even lead to death as the lack of
blood flow can severely damage the heart, brain, and other organs. Arrhythmia monitoring
devices are tremendously useful in tracking the function of the heart and report any
abnormalities in rhythm of heart.
Request Free Sample Copy
@ https://www.marketresearchfuture.com/sample_request/6714
Factors such as growing occurrence of cardiovascular diseases such premature contraction,
conduction disorders, atrial fibrillation, tachycardia globally will fuel the growth of global
cardiac arrhythmia monitoring devices market during the forecast period.
According to American College of Cardiology, the number of cases of cardiovascular disease
worldwide accounted for 422.7 million in 2015, out of which 46.1 million people suffered
from atrial fibrillation. Increasing awareness about prevention and treatment of cardiac
diseases will develop the demand for these devices thus enhancing the industry growth in
the forthcoming years.
Moreover, these adverse impacts could additionally limit the adoption of these devices and
hinder the growth of the industry over the forecast period.
Segmentation:
The global arrhythmia monitoring devices market has been segmented on the devices,
service providers, application, and end users.
On the basis of devices, the market has been classified as Implantable cardiac monitors,
mobile cardiac telemetry devices, resting ECG devices, ECG stress test devices, holter
monitors and others. On the basis of service providers, the market has been classified as
mobile cardiac telemetry monitoring service providers, independent diagnostic testing
facilities/clinics, others. On the basis of application, the market has been classified as
bradycardia, tachycardia, atrial fibrillation, ventricular fibrillation, premature contraction,
conduction disorders and others. On the basis of end users, the market has been classified
as hospitals & clinics, ambulatory surgery centers, diagnostic centers, home care settings,
long term care centers, emergency medical services.
Key Players:
Some of the key players in the global arrhythmia monitoring devices market are Cardiac
Science Corporation, NUUBO Smart Solutions Technologies, Koninklijke Philips, GE
Healthcare, Welch Allyn, Spacelabs Healthcare, Nihon Kohden Corporation, Fukuda Denshi,
BioTelemetry, Inc., AliveCor, Inc., Biotronik, Medtronic, Abbott, Applied Cardiac Systems,
Aurora Resurgence, iRhythm Technologies, Inc., Medi-Lynx Cardiac Monitoring, Preventice
Solutions, Inc.
Browse Complete Report Details
@ https://www.marketresearchfuture.com/reports/arrhythmia-monitoring-devices-market-
6714
Regional Analysis:
The Americas is projected to lead the arrhythmia monitoring devices market in the forecast
period. Increasing healthcare awareness, advancement in technology, medical tourism are
some other factors that boost the growth of the market. The US arrythmia monitoring
devices market dominated industry in 2017, due to the high demand for quality healthcare,
vastly developed healthcare infrastructure as well as growing occurrence of cardiac disease
in the region. Frequencies of cardiac arrythmia are dramatically increasing over the last few
years. Growing adoption of advanced technologies such as remote patient monitoring that
offer smart, easy-to-use and portable devices will fuel the demand for cardiac arrhythmia
monitoring devices. Fa.